Literature DB >> 1948112

Combined exercise radionuclide angiocardiography and single photon emission computed tomography perfusion studies for assessment of coronary artery disease.

S Borges-Neto1, R E Coleman, J M Potts, R H Jones.   

Abstract

Although there is widespread use of exercise thallium 201 scintigraphy and radionuclide angiocardiography in patients with coronary artery disease (CAD), little is known about the independence, concordance, or relative importance of these studies in the diagnosis, prognosis, and assessment of the outcome of therapy. The use of both tests in the same patient has been impractical because of the logistic considerations imposed by two exercise tests on separate days, and excessive radiation exposure. New technetium 99m-labeled radiopharmaceuticals with high myocardial extraction now permit the simultaneous assessment of myocardial perfusion (single photon emission computed tomography [SPECT]) and ventricular function (radionuclide angiocardiography [RNA]) during treadmill exercise (exercise tolerance test [ETT]). The ability to perform all three tests during a single exercise session offers a very attractive technique to evaluate patients with CAD. The investigators studied 86 patients with chronic CAD using the same-day perfusion and function protocol combined with treadmill exercise. The results demonstrate good concordance between myocardial perfusion and ventricular function as indicated by a significant correlation between tomographic perfusion defect size and ejection fraction (P less than .0001, R = 0.75 at rest and P less than .0001, R = 0.76 during exercise). Stepwise logistic regression was used to model ETT, RNA, and SPECT variables against the presence of one or more 60% stenoses by quantitative angiography, an end point present in 47 patients. Univariable analysis showed all three tests (ETT, RNA, and SPECT) to be significant predictors of the end points (lambda 2 = 5.1, P less than .05; lambda 2 = 12.5, P less than .001; and lambda 2 = 16.1, P less than .001, respectively). Multivariable analysis demonstrated that SPECT provided more diagnostic information than ETT and RNA (Lambda 2 = 16.1, P less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1948112     DOI: 10.1016/s0001-2998(05)80042-x

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  16 in total

1.  First-pass radionuclide angiography.

Authors:  John D Friedman; Daniel S Berman; Salvador Borges-Neto; Sean W Hayes; Lynne L Johnson; Kenneth J Nichols; Robert A Pagnanelli; Steven C Port
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

2.  Myocardial perfusion and function single photon emission computed tomography.

Authors:  Christopher L Hansen; Richard A Goldstein; Daniel S Berman; Keith B Churchwell; C David Cooke; James R Corbett; S James Cullom; Seth T Dahlberg; James R Galt; Ravi K Garg; Gary V Heller; Mark C Hyun; Lynne L Johnson; April Mann; Benjamin D McCallister; Raymond Taillefer; R Parker Ward; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 3.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

4.  Comparison of technetium-99m sestamibi left ventricular wall motion and perfusion studies with thallium-201 perfusion imaging: in search of the combination of variables with the highest accuracy in predicting coronary artery disease.

Authors:  J F Verzijlbergen; A H Zwinderman; C A Ascoop; E E van der Wall; M G Niemeyer; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1996-05

5.  Repeatability of treadmill exercise ejection fraction and wall motion using technetium 99m-labeled sestamibi first-pass radionuclide ventriculography.

Authors:  B Benari; H Kiat; J Erel; M Hyun; F P Wang; C Williams; J D Friedman; G Germano; K F Van Train; D Berman
Journal:  J Nucl Cardiol       Date:  1995 Nov-Dec       Impact factor: 5.952

6.  Clinical application of radionuclide angiography.

Authors:  S C Port; F J Wackers
Journal:  J Nucl Cardiol       Date:  1995 Nov-Dec       Impact factor: 5.952

7.  Imaging guidelines for nuclear cardiology procedures. American Society of Nuclear Cardiology. First-pass radionuclide angiography (FPRNA).

Authors: 
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

8.  Prediction of severe coronary artery disease by combined rest and exercise radionuclide angiocardiography and tomographic perfusion imaging with technetium 99m-labeled sestamibi: a comparison with clinical and electrocardiographic data.

Authors:  S Borges-Neto; L J Shaw; K L Kesler; M W Hanson; E D Peterson; E I Morris; R E Coleman
Journal:  J Nucl Cardiol       Date:  1997 May-Jun       Impact factor: 5.952

Review 9.  First-pass radionuclide angiocardiography with single-crystal gamma cameras.

Authors:  K Nichols; E G DePuey; A Rozanski
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

10.  The differing prognostic utility of exercise radionuclide ventriculography in coronary artery disease patients with and without prior myocardial infarction.

Authors:  M Moriel; A Rozanski; J Klein; D S Berman; C N Merz
Journal:  Int J Card Imaging       Date:  1997-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.